Home / Blood Tests / ROMA-PRE
ROMA-PRE
Overview of the ROMA™ Test
The Risk of Ovarian Malignancy Algorithm (ROMA™) test is designed to evaluate the likelihood of ovarian cancer in women presenting with a pelvic mass.
Key Factors Assessed
The test combines measurements of HE4 and CA125 biomarkers along with the patient’s menopausal status.
Purpose and Clinical Use
ROMA™ helps healthcare providers assess the risk of ovarian malignancy to support timely and accurate clinical decision-making.
There is an additional £20 phlebotomy fee for every donation.
| Price | £87.0 |
|---|---|
| Categories | | All |
| Turnaround Time | nan |
| LIS Code | ROMA-PRE |
| Exams Included | No Markers Included |
| Enquire Now (020 3633 2371) WhatsApp Now (+4474 4807 7654) |